Abstract
We report a case of advanced squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to oral chemotherapy with TS-1. The patient was an 89-year-old female with severe dementia. We carried out chemotherapy with TS-1 50 mg/day, without surgical treatment. The tumor disappeared clinically at 4 months after 3 courses of the TS-1 administration. Adverse drug reactions, including vomiting, leukopenia and thrombopenia, forced a stop of the administration of TS-1. Although she finally died of in senescence 2 months from the cease of administration, there was no recurrence of the cancer at the time.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Aged, 80 and over
-
Antimetabolites, Antineoplastic / adverse effects
-
Antimetabolites, Antineoplastic / therapeutic use*
-
Carcinoma, Squamous Cell / drug therapy*
-
Carcinoma, Squamous Cell / pathology*
-
Drug Administration Schedule
-
Drug Combinations
-
Female
-
Gingival Neoplasms / pathology*
-
Humans
-
Leukopenia / chemically induced
-
Maxillary Sinus Neoplasms / pathology*
-
Mouth Mucosa / pathology
-
Mouth Neoplasms / drug therapy*
-
Mouth Neoplasms / pathology*
-
Neoplasm Invasiveness
-
Oxonic Acid / adverse effects
-
Oxonic Acid / therapeutic use*
-
Pyridines / adverse effects
-
Pyridines / therapeutic use*
-
Remission Induction
-
Tegafur / adverse effects
-
Tegafur / therapeutic use*
-
Thrombocytopenia / chemically induced
-
Vomiting, Anticipatory / etiology
Substances
-
Antimetabolites, Antineoplastic
-
Drug Combinations
-
Pyridines
-
S 1 (combination)
-
Tegafur
-
Oxonic Acid